RNA based method to obtain stably integrated retroviral vectors
US10378026B2 · kind B2 · utility
4Cited by
0References
11Claims
0Family size
Assignee
Inventors
Key dates
| Filing date | Sep 2, 2014 |
| Grant date | Aug 13, 2019 |
| Priority date | — |
| Expiry date | Mar 28, 2035 |
Classification
- Technology area (CPC C)Chemistry; Metallurgy
- CPC primaryC12N2740/17052
- WIPO fieldBiotechnology
- WIPO sectorChemistry
Abstract
The present invention relates to viral transformation method, particularly foamy virus-mediated transformation method. The present invention relates to the transfer of transgene into cells by the safe and efficient transfer of RNA encoding foamy components. The present invention has therefore therapeutic interest, especially in the field of gene therapy.
Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.